Search research articles
Contact Us
Filters
Showing results (151-160 of 224) with videos related to
Page
of 23
Sort By:
Headache
|
March 19, 2010
Electronic medical records as a research tool: evaluating topiramate use at a headache center
Michael J Marmura, Mary Hopkins, Jocelyn Andrel, et al.
Cephalalgia : an International Journal of Headache
|
February 21, 2020
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina, Joel Saper, Roger Cady, et al.
American Journal of Physiology. Renal Physiology
|
January 17, 2025
Ribosomal s6 kinase is a mediator of aquaporin-2 S256 phosphorylation and membrane accumulation after EGFR inhibition with erlotinib
Richard S E Babicz, Noah Baylor, Abby Terlouw, et al.
Biophysical Journal
|
October 21, 2020
Synergistic Allostery in Multiligand-Protein Interactions
Abhijeet Ghode, Lissy Z F Gross, Wei-Ven Tee, et al.
Bone and Mineral
|
December 1, 1991
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
M Passeri, M C Baroni, M Pedrazzoni, et al.
Molecular Carcinogenesis
|
August 24, 2018
DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477)
Isabel M Weßbecher, Inga Hinrichsen, Sebastian Funke, et al.
The Journal of Frailty & Aging
|
February 5, 2022
Frailty in Caregivers and Its Relationship with Psychological Stress and Resilience: A Cross-SectionalStudy Based on the Deficit Accumulation Model
M Canevelli, F S Bersani, F Sciancalepore, et al.
The EMBO Journal
|
August 10, 2002
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
Ricardo M Biondi, David Komander, Christine C Thomas, et al.
Journal of Medicinal Chemistry
|
July 18, 2009
3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds
Adriana Stroba, Francis Schaeffer, Valerie Hindie, et al.
The Journal of Headache and Pain
|
October 7, 2020
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study
Stephen Silberstein, Merle Diamond, Nada A Hindiyeh, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 224) with videos related to
Sort By:
Page
of 23
Headache
|
March 19, 2010
Electronic medical records as a research tool: evaluating topiramate use at a headache center
Michael J Marmura, Mary Hopkins, Jocelyn Andrel, et al.
Cephalalgia : an International Journal of Headache
|
February 21, 2020
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina, Joel Saper, Roger Cady, et al.
American Journal of Physiology. Renal Physiology
|
January 17, 2025
Ribosomal s6 kinase is a mediator of aquaporin-2 S256 phosphorylation and membrane accumulation after EGFR inhibition with erlotinib
Richard S E Babicz, Noah Baylor, Abby Terlouw, et al.
Biophysical Journal
|
October 21, 2020
Synergistic Allostery in Multiligand-Protein Interactions
Abhijeet Ghode, Lissy Z F Gross, Wei-Ven Tee, et al.
Bone and Mineral
|
December 1, 1991
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
M Passeri, M C Baroni, M Pedrazzoni, et al.
Molecular Carcinogenesis
|
August 24, 2018
DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477)
Isabel M Weßbecher, Inga Hinrichsen, Sebastian Funke, et al.
The Journal of Frailty & Aging
|
February 5, 2022
Frailty in Caregivers and Its Relationship with Psychological Stress and Resilience: A Cross-SectionalStudy Based on the Deficit Accumulation Model
M Canevelli, F S Bersani, F Sciancalepore, et al.
The EMBO Journal
|
August 10, 2002
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
Ricardo M Biondi, David Komander, Christine C Thomas, et al.
Journal of Medicinal Chemistry
|
July 18, 2009
3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds
Adriana Stroba, Francis Schaeffer, Valerie Hindie, et al.
The Journal of Headache and Pain
|
October 7, 2020
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study
Stephen Silberstein, Merle Diamond, Nada A Hindiyeh, et al.
Page
of 23